Literature DB >> 15699156

Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity.

Bruce J Shenker1, Dave Besack, Terry McKay, Lisa Pankoski, Ali Zekavat, Donald R Demuth.   

Abstract

We have previously shown that Actinobacillus actinomycetemcomitans produces an immunosuppressive factor encoded by the cytolethal distending toxin (cdt)B gene. In this study, we used rCdt peptides to study the contribution of each subunit to toxin activity. As previously reported, CdtB is the only Cdt subunit that is capable of inducing cell cycle arrest by itself. Although CdtA and CdtC do not exhibit activity alone, each subunit is able to significantly enhance the ability of CdtB to induce G2 arrest in Jurkat cells; these effects were dependent upon protein concentration. Moreover, the combined addition of both CdtA and CdtC increased the ED50 for CdtB >7000-fold. In another series of experiments, we demonstrate that the three Cdt peptides are able to form a functional toxin unit on the cell surface. However, these interactions first require that a complex forms between the CdtA and CdtC subunits, indicating that these peptides are required for interaction between the cell and the holotoxin. This conclusion is further supported by experiments in which both Jurkat cells and normal human lymphocytes were protected from Cdt holotoxin-induced G2 arrest by pre-exposure to CdtA and CdtC. Finally, we have used optical biosensor technology to show that CdtA and CdtC have a strong affinity for one another (10(-7) M). Furthermore, although CdtB is unable to bind to either CdtA or CdtC alone, it is capable of forming a stable complex with CdtA/CdtC. The implications of our results with respect to the function and structure of the Cdt holotoxin are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699156     DOI: 10.4049/jimmunol.174.4.2228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase.

Authors:  Bruce J Shenker; Kathleen Boesze-Battaglia; Ali Zekavat; Lisa Walker; Dave Besack; Hydar Ali
Journal:  Mol Immunol       Date:  2010-09-21       Impact factor: 4.407

2.  Exposure of lymphocytes to high doses of Actinobacillus actinomycetemcomitans cytolethal distending toxin induces rapid onset of apoptosis-mediated DNA fragmentation.

Authors:  Bruce J Shenker; Donald R Demuth; Ali Zekavat
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

3.  Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol.

Authors:  Kathleen Boesze-Battaglia; Angela Brown; Lisa Walker; Dave Besack; Ali Zekavat; Steve Wrenn; Claude Krummenacher; Bruce J Shenker
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

4.  Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.

Authors:  Chia-Der Lin; Cheng-Kuo Lai; Yu-Hsin Lin; Jer-Tsong Hsieh; Yu-Ting Sing; Yun-Chieh Chang; Kai-Chuan Chen; Wen-Ching Wang; Hong-Lin Su; Chih-Ho Lai
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

5.  Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate.

Authors:  B J Shenker; L P Walker; A Zekavat; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2015-09-24       Impact factor: 3.563

Review 6.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

7.  Characterization of Aggregatibacter actinomycetemcomitans strains in periodontitis patients in Germany.

Authors:  Holger Jentsch; Georg Cachovan; Arndt Guentsch; Peter Eickholz; Wolfgang Pfister; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2012-01-14       Impact factor: 3.573

8.  Cytolethal distending toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase- independent death in a Saccharomyces cerevisiae model.

Authors:  Oranart Matangkasombut; Roongtiwa Wattanawaraporn; Keiko Tsuruda; Masaru Ohara; Motoyuki Sugai; Skorn Mongkolsuk
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

9.  Cytolethal distending toxin-induced release of interleukin-1β by human macrophages is dependent upon activation of glycogen synthase kinase 3β, spleen tyrosine kinase (Syk) and the noncanonical inflammasome.

Authors:  Bruce J Shenker; Lisa M Walker; Zeyed Zekavat; David M Ojcius; Pei-Rong Huang; Kathleen Boesze-Battaglia
Journal:  Cell Microbiol       Date:  2020-03-04       Impact factor: 3.715

10.  The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization.

Authors:  Kathleen Boesze-Battaglia; Lisa P Walker; Ali Zekavat; Mensur Dlakić; Monika Damek Scuron; Patrik Nygren; Bruce J Shenker
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.